| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.04 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |